Study details
Enrolling now
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
Evon Medics LLC
NCT IDNCT06434818ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
300
Study length
about 2 years
Ages
18–80
Locations
3 sites in DC, MD
About this study
This trial is testing a new device called EDITOR to help people manage substance use disorders. It involves using digital and chemosensory training, along with remote monitoring. The goal is to see if this device helps people stay in treatment and avoid using substances.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take CBOT Sham
- 2.Take CBOT with olfactory stimulants & OFC tasks
- 3.Use EDITOR (CBOT with olfactory stimulants, OFC tasks & remote monitoring of treatment compliance)
PhasePhase 2
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low11%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Body systems
Psychiatry / Mental Health